Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.

Ueda T, Honda M, Horimoto K, Aburatani S, Saito S, Yamashita T, Sakai Y, Nakamura M, Takatori H, Sunagozaka H, Kaneko S.

Genomics. 2013 Apr;101(4):238-48. doi: 10.1016/j.ygeno.2013.02.007. Epub 2013 Feb 26. Erratum in: Genomics. 2013 Jun;101(6):376.

2.

Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.

Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S.

Hepatology. 2009 Apr;49(4):1098-112. doi: 10.1002/hep.22749.

PMID:
19173277
3.

Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.

Yu MC, Lee YS, Lin SE, Wu HY, Chen TC, Lee WC, Chen MF, Tsai CN.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S455-63. doi: 10.1245/s10434-011-1946-2. Epub 2011 Aug 6.

PMID:
21822558
4.
5.

Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.

Liao R, Wu H, Yi Y, Wang JX, Cai XY, He HW, Cheng YF, Zhou J, Fan J, Sun J, Qiu SJ.

J Exp Clin Cancer Res. 2013 Apr 19;32:22. doi: 10.1186/1756-9966-32-22.

6.

Transcriptional profiling identifies gene expression changes associated with IFN-alpha tolerance in hepatitis C-related hepatocellular carcinoma cells.

Wong N, Chan KY, Macgregor PF, Lai PB, Squire JA, Beheshti B, Albert M, Leung TW.

Clin Cancer Res. 2005 Feb 1;11(3):1319-26.

7.

Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus.

Zekri AR, Hassan ZK, Bahnassy AA, Sherif GM, ELdahshan D, Abouelhoda M, Ali A, Hafez MM.

Asian Pac J Cancer Prev. 2012;13(11):5433-8.

8.

Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.

Lee HH, Uen YH, Tian YF, Sun CS, Sheu MJ, Kuo HT, Koay LB, Lin CY, Tzeng CC, Cheng CJ, Tang LY, Tsai SL, Wang AH.

Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1562-9. doi: 10.1158/1055-9965.EPI-09-0039.

9.

Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma.

Lee CF, Ling ZQ, Zhao T, Lee KR.

World J Gastroenterol. 2008 Oct 21;14(39):6072-7.

10.
11.

Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus-associated hepatocellular carcinoma.

Melis M, Diaz G, Kleiner DE, Zamboni F, Kabat J, Lai J, Mogavero G, Tice A, Engle RE, Becker S, Brown CR, Hanson JC, Rodriguez-Canales J, Emmert-Buck M, Govindarajan S, Kew M, Farci P.

J Transl Med. 2014 Aug 21;12:230. doi: 10.1186/s12967-014-0230-1.

12.

Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.

Xia L, Huang W, Tian D, Zhu H, Zhang Y, Hu H, Fan D, Nie Y, Wu K.

J Hepatol. 2012 Sep;57(3):600-12. doi: 10.1016/j.jhep.2012.04.020. Epub 2012 May 18.

PMID:
22613004
13.

Differential gene expression profiles of hepatocellular carcinomas associated or not with viral infection.

Bellodi-Privato M, Kubrusly MS, Stefano JT, Soares IC, Wakamatsu A, Oliveira AC, Alves VA, Bacchella T, Machado MC, D'Albuquerque LA.

Braz J Med Biol Res. 2009 Dec;42(12):119-1127. Epub 2009 Nov 6.

14.

Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.

Kurokawa Y, Honma K, Takemasa I, Nakamori S, Kita-Matsuo H, Motoori M, Nagano H, Dono K, Ochiya T, Monden M, Kato K.

Int J Oncol. 2006 Feb;28(2):383-91.

PMID:
16391793
15.

Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.

Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S.

J Viral Hepat. 2005 Nov;12(6):635-41.

PMID:
16255765
16.

Hepatitis virus infection affects DNA methylation in mice with humanized livers.

Okamoto Y, Shinjo K, Shimizu Y, Sano T, Yamao K, Gao W, Fujii M, Osada H, Sekido Y, Murakami S, Tanaka Y, Joh T, Sato S, Takahashi S, Wakita T, Zhu J, Issa JP, Kondo Y.

Gastroenterology. 2014 Feb;146(2):562-72. doi: 10.1053/j.gastro.2013.10.056. Epub 2013 Oct 30.

PMID:
24184133
17.

microRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection.

Spaniel C, Honda M, Selitsky SR, Yamane D, Shimakami T, Kaneko S, Lanford RE, Lemon SM.

PLoS One. 2013 Oct 9;8(10):e76867. doi: 10.1371/journal.pone.0076867. eCollection 2013.

18.

The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.

Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.

J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. Erratum in: J Exp Clin Cancer Res 2000 Mar;19(1):125.

PMID:
10606185
19.

Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.

Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S, Hamamoto Y.

Cancer Res. 2002 Jul 15;62(14):3939-44.

20.

Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma.

Smith MW, Yue ZN, Geiss GK, Sadovnikova NY, Carter VS, Boix L, Lazaro CA, Rosenberg GB, Bumgarner RE, Fausto N, Bruix J, Katze MG.

Cancer Res. 2003 Feb 15;63(4):859-64.

Items per page

Supplemental Content

Write to the Help Desk